Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
These teams track each case across PBMs, submit appeals, and sometimes help patients choose specific GLP-1 brands based on their insurance
How did the drug Wegovy/Ozempic get approved by the FDA
Setting expectations for each phase prevents discouragement when the pace naturally changes
Japan Tirzepatide Market Analysis and Trends Japan continues to lead in the Tirzepatide market within Asia Pacific through its rigorous regulatory framework and strong emphasis on quality standards